Safety Evaluation of Monophosphoryl Lipid A (MPL): An Immunostimulatory Adjuvant

Author： Baldrick P. Richardson D. Elliott G. Wheeler A.W.

ISSN： 0273-2300

Source： Regulatory Toxicology and Pharmacology, Vol.35, Iss.3, 2002-06, pp. : 398-413

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunostimulatory biodegradable implants containing the adjuvant Quil-A—Part II: In vivo evaluation

By Myschik Julia Mcburney Warren Hennessy Tania Phipps-Green Amanda Rades Thomas Hook Sarah

Journal of Drug Targeting, Vol. 16, Iss. 3, 2008-04 ,pp. : 224-232

Informa Healthcare

Access to resources Recommend Favorite

The Protective Effects of Monophosphoryl Lipid A on the Ischemic Myocardium and Endothelium in Rats

By Zhu Hui-Qing Jiang Jun-Lin Lu Rong Zhang Xiao-Hong Deng Han-Wu Li Yuan-Jian

Cardiovascular Drugs and Therapy, Vol. 17, Iss. 4, 2003-07 ,pp. : 311-318

Springer Publishing Company

Access to resources Recommend Favorite

Immunostimulatory biodegradable implants containing the adjuvant Quil-A—Part I: Physicochemical characterisation

By Myschik Julia Eberhardt Friederike Rades Thomas Hook Sarah

Journal of Drug Targeting, Vol. 16, Iss. 3, 2008-04 ,pp. : 213-223

Informa Healthcare

Access to resources Recommend Favorite

Clinical Trial for Safety Evaluation of Hyaluronidase as Diffusion Enhancing Adjuvant for Infiltration Analgesia of Skin with Lidocaine

By Wohlrab Johannes Finke Rainer Franke Walter G. Wohlrab Angelika

Dermatologic Surgery, Vol. 38, Iss. 1, 2012-01 ,pp. : 91-96

Elsevier

Access to resources Recommend Favorite

Delayed protection against ventricular arrhythmias by monophosphoryl lipid-A in a canine model of ischaemia and reperfusion

By Vegh A. Gyorgy K. Rastegar M.A. Papp J.G. Parratt J.R.

European Journal of Pharmacology, Vol. 382, Iss. 2, 1999-10 ,pp. : 81-90

Elsevier

Access to resources Recommend Favorite